Should retatrutide receive a positive regulatory decision, it would then be subject to a health technology appraisal (HTA) by NICE (National Institute for Health and Care Excellence) to determine its clinical and cost-effectiveness relative to existing treatments
Potential risks include hormone imbalances, effects on blood sugar levels, and increased IGF-1 (insulin-like growth factor) levels, which may lead to other risks over time
In another study, Semaglutide was shown to be clinically efficient in facilitating weight loss at 3 and 6 months for individuals with overweight or obesity
found defective insulin levels and impaired PI3K/AKT/mTOR signaling pathways in the ovary and endometrium of patients with PCOS ( 2 O 2 -induced oxidative stress and autophagy levels in FGCs, via the PI3K/AKT/mTOR signaling pathway (Xu et al., 2022)
Available in 5 MG and 10 MG vials, supplied as lyophilized powder for reconstitution
Only pre-formulated blends are designed for that